TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - STD TI - Ni XF, Wu J, Ji M, Shao YJ, Xu B, Jiang JT, et al. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer. Asia Pac J Clin Oncol. 2018. ID - ref2 ER - TY - JOUR AU - Pechoux, C. PY - 2011 DA - 2011// TI - Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data JO - Oncologist. VL - 16 UR - https://doi.org/10.1634/theoncologist.2010-0150 DO - 10.1634/theoncologist.2010-0150 ID - Pechoux2011 ER - TY - JOUR AU - Crino, L. AU - Weder, W. AU - Meerbeeck, J. AU - Felip, E. PY - 2010 DA - 2010// TI - Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq207 DO - 10.1093/annonc/mdq207 ID - Crino2010 ER - TY - JOUR AU - Rothschild, S. I. PY - 2013 DA - 2013// TI - Epigenetic therapy in lung Cancer - role of microRNAs JO - Front Oncol VL - 3 UR - https://doi.org/10.3389/fonc.2013.00158 DO - 10.3389/fonc.2013.00158 ID - Rothschild2013 ER - TY - JOUR AU - Osmani, L. AU - Askin, F. AU - Gabrielson, E. AU - Li, Q. K. PY - 2018 DA - 2018// TI - Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy JO - Semin Cancer Biol VL - 52 UR - https://doi.org/10.1016/j.semcancer.2017.11.019 DO - 10.1016/j.semcancer.2017.11.019 ID - Osmani2018 ER - TY - JOUR AU - Lim, S. W. AU - Ahn, M. J. PY - 2019 DA - 2019// TI - Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer JO - Korean J Intern Med VL - 34 UR - https://doi.org/10.3904/kjim.2018.179 DO - 10.3904/kjim.2018.179 ID - Lim2019 ER - TY - JOUR AU - Lindeman, N. I. AU - Cagle, P. T. AU - Beasley, M. B. AU - Chitale, D. A. AU - Dacic, S. AU - Giaccone, G. PY - 2013 DA - 2013// TI - Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology JO - J Mol Diagn VL - 15 UR - https://doi.org/10.1016/j.jmoldx.2013.03.001 DO - 10.1016/j.jmoldx.2013.03.001 ID - Lindeman2013 ER - TY - JOUR AU - Nilssen, Y. AU - Strand, T. E. AU - Fjellbirkeland, L. AU - Bartnes, K. AU - Moller, B. PY - 2016 DA - 2016// TI - Lung cancer survival in Norway, 1997-2011: from nihilism to optimism JO - Eur Respir J VL - 47 UR - https://doi.org/10.1183/13993003.00650-2015 DO - 10.1183/13993003.00650-2015 ID - Nilssen2016 ER - TY - JOUR AU - Vijayvergia, N. AU - Shah, P. C. AU - Denlinger, C. S. PY - 2015 DA - 2015// TI - Survivorship in non-small cell lung Cancer: challenges faced and steps forward JO - J Natl Compr Cancer Netw VL - 13 UR - https://doi.org/10.6004/jnccn.2015.0140 DO - 10.6004/jnccn.2015.0140 ID - Vijayvergia2015 ER - TY - JOUR AU - Mantovani, A. AU - Allavena, P. AU - Sica, A. AU - Balkwill, F. PY - 2008 DA - 2008// TI - Cancer-related inflammation JO - Nature. VL - 454 UR - https://doi.org/10.1038/nature07205 DO - 10.1038/nature07205 ID - Mantovani2008 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell. VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Balkwill, F. AU - Mantovani, A. PY - 2001 DA - 2001// TI - Inflammation and cancer: back to Virchow? JO - Lancet. VL - 357 UR - https://doi.org/10.1016/S0140-6736(00)04046-0 DO - 10.1016/S0140-6736(00)04046-0 ID - Balkwill2001 ER - TY - JOUR AU - Ghezzi, F. AU - Cromi, A. AU - Siesto, G. AU - Giudici, S. AU - Serati, M. AU - Formenti, G. PY - 2010 DA - 2010// TI - Prognostic significance of preoperative plasma fibrinogen in endometrial cancer JO - Gynecol Oncol VL - 119 UR - https://doi.org/10.1016/j.ygyno.2010.07.014 DO - 10.1016/j.ygyno.2010.07.014 ID - Ghezzi2010 ER - TY - JOUR AU - Sun, Z. Q. AU - Han, X. N. AU - Wang, H. J. AU - Tang, Y. AU - Zhao, Z. L. AU - Qu, Y. L. PY - 2014 DA - 2014// TI - Prognostic significance of preoperative fibrinogen in patients with colon cancer JO - World J Gastroenterol VL - 20 UR - https://doi.org/10.3748/wjg.v20.i26.8583 DO - 10.3748/wjg.v20.i26.8583 ID - Sun2014 ER - TY - JOUR AU - Kijima, T. AU - Arigami, T. AU - Uchikado, Y. AU - Uenosono, Y. AU - Kita, Y. AU - Owaki, T. PY - 2017 DA - 2017// TI - Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma JO - Cancer Sci VL - 108 UR - https://doi.org/10.1111/cas.13127 DO - 10.1111/cas.13127 ID - Kijima2017 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Coussens, L. M. AU - Werb, Z. PY - 2002 DA - 2002// TI - Inflammation and cancer JO - Nature. VL - 420 UR - https://doi.org/10.1038/nature01322 DO - 10.1038/nature01322 ID - Coussens2002 ER - TY - JOUR AU - Mittal, V. AU - Rayes, T. AU - Narula, N. AU - McGraw, T. E. AU - Altorki, N. K. AU - Barcellos-Hoff, M. H. PY - 2016 DA - 2016// TI - The microenvironment of lung Cancer and therapeutic implications JO - Adv Exp Med Biol VL - 890 UR - https://doi.org/10.1007/978-3-319-24932-2_5 DO - 10.1007/978-3-319-24932-2_5 ID - Mittal2016 ER - TY - JOUR AU - Artigas, A. AU - Wernerman, J. AU - Arroyo, V. AU - Vincent, J. L. AU - Levy, M. PY - 2016 DA - 2016// TI - Role of albumin in diseases associated with severe systemic inflammation: pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis JO - J Crit Care VL - 33 UR - https://doi.org/10.1016/j.jcrc.2015.12.019 DO - 10.1016/j.jcrc.2015.12.019 ID - Artigas2016 ER - TY - JOUR AU - Gupta, D. AU - Lis, C. G. PY - 2010 DA - 2010// TI - Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature JO - Nutr J VL - 9 UR - https://doi.org/10.1186/1475-2891-9-69 DO - 10.1186/1475-2891-9-69 ID - Gupta2010 ER - TY - JOUR AU - Zitvogel, L. AU - Pietrocola, F. AU - Kroemer, G. PY - 2017 DA - 2017// TI - Nutrition, inflammation and cancer JO - Nat Immunol VL - 18 UR - https://doi.org/10.1038/ni.3754 DO - 10.1038/ni.3754 ID - Zitvogel2017 ER - TY - JOUR AU - Jensen, T. AU - Kierulf, P. AU - Sandset, P. M. AU - Klingenberg, O. AU - Joo, G. B. AU - Godal, H. C. PY - 2007 DA - 2007// TI - Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells JO - Thromb Haemost VL - 97 UR - https://doi.org/10.1160/TH07-01-0039 DO - 10.1160/TH07-01-0039 ID - Jensen2007 ER - TY - JOUR AU - Chen, S. AU - Yan, H. AU - Du, J. AU - Li, J. AU - Shen, B. AU - Ying, H. PY - 2018 DA - 2018// TI - Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: a propensity score matching analysis JO - Clin Chim Acta VL - 482 UR - https://doi.org/10.1016/j.cca.2018.04.012 DO - 10.1016/j.cca.2018.04.012 ID - Chen2018 ER - TY - JOUR AU - Palumbo, J. S. AU - Kombrinck, K. W. AU - Drew, A. F. AU - Grimes, T. S. AU - Kiser, J. H. AU - Degen, J. L. PY - 2000 DA - 2000// TI - Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells JO - Blood. VL - 96 ID - Palumbo2000 ER - TY - JOUR AU - Allin, K. H. AU - Bojesen, S. E. AU - Nordestgaard, B. G. PY - 2016 DA - 2016// TI - Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population JO - Int J Cancer VL - 139 UR - https://doi.org/10.1002/ijc.30194 DO - 10.1002/ijc.30194 ID - Allin2016 ER - TY - JOUR AU - Sheng, L. AU - Luo, M. AU - Sun, X. AU - Lin, N. AU - Mao, W. AU - Su, D. PY - 2013 DA - 2013// TI - Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer JO - Int J Cancer VL - 133 ID - Sheng2013 ER - TY - JOUR AU - Jones, J. M. AU - McGonigle, N. C. AU - McAnespie, M. AU - Cran, G. W. AU - Graham, A. N. PY - 2006 DA - 2006// TI - Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer JO - Lung Cancer VL - 53 UR - https://doi.org/10.1016/j.lungcan.2006.03.012 DO - 10.1016/j.lungcan.2006.03.012 ID - Jones2006 ER - TY - JOUR AU - Morano, M. T. AU - Mesquita, R. AU - Silva, G. P. AU - Araujo, A. S. AU - Pinto, J. M. AU - Neto, A. G. PY - 2014 DA - 2014// TI - Comparison of the effects of pulmonary rehabilitation with chest physical therapy on the levels of fibrinogen and albumin in patients with lung cancer awaiting lung resection: a randomized clinical trial JO - BMC Pulm Med VL - 14 UR - https://doi.org/10.1186/1471-2466-14-121 DO - 10.1186/1471-2466-14-121 ID - Morano2014 ER - TY - JOUR AU - Grivennikov, S. I. AU - Greten, F. R. AU - Karin, M. PY - 2010 DA - 2010// TI - Immunity, inflammation, and cancer JO - Cell. VL - 140 UR - https://doi.org/10.1016/j.cell.2010.01.025 DO - 10.1016/j.cell.2010.01.025 ID - Grivennikov2010 ER - TY - JOUR AU - Matsuda, S. AU - Takeuchi, H. AU - Kawakubo, H. AU - Fukuda, K. AU - Nakamura, R. AU - Suda, K. PY - 2017 DA - 2017// TI - Prognostic impact of change in the fibrinogen and albumin score during preoperative treatment in esophageal Cancer patients JO - World J Surg VL - 41 UR - https://doi.org/10.1007/s00268-017-4074-8 DO - 10.1007/s00268-017-4074-8 ID - Matsuda2017 ER - TY - JOUR AU - Svaton, M. AU - Zemanova, M. AU - Skrickova, J. AU - Jakubikova, L. AU - Kolek, V. AU - Kultan, J. PY - 2018 DA - 2018// TI - Chronic inflammation as a potential predictive factor of Nivolumab therapy in non-small cell lung Cancer JO - Anticancer Res VL - 38 UR - https://doi.org/10.21873/anticanres.13048 DO - 10.21873/anticanres.13048 ID - Svaton2018 ER - TY - JOUR AU - Kim, J. H. AU - Kim, H. S. AU - Kim, B. J. PY - 2017 DA - 2017// TI - Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: a meta-analysis and review JO - Oncotarget. VL - 8 ID - Kim2017 ER - TY - JOUR AU - Hamilton, G. AU - Rath, B. PY - 2018 DA - 2018// TI - Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1 JO - Expert Opin Drug Metab Toxicol VL - 14 UR - https://doi.org/10.1080/17425255.2018.1416095 DO - 10.1080/17425255.2018.1416095 ID - Hamilton2018 ER - TY - JOUR AU - Nie, X. AU - Cheng, G. AU - Ai, B. AU - Zhang, S. PY - 2013 DA - 2013// TI - The tailored chemotherapy based on RRM1 immunohistochemical expression in patients with advanced non-small cell lung cancer JO - Cancer Biomark VL - 13 UR - https://doi.org/10.3233/CBM-130381 DO - 10.3233/CBM-130381 ID - Nie2013 ER - TY - JOUR AU - Huang, Z. L. AU - Cao, X. AU - Luo, R. Z. AU - Chen, Y. F. AU - Zhu, L. C. AU - Wen, Z. PY - 2016 DA - 2016// TI - Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: a prospective study JO - Oncol Lett VL - 11 UR - https://doi.org/10.3892/ol.2015.3894 DO - 10.3892/ol.2015.3894 ID - Huang2016 ER - TY - JOUR AU - Wang, L. R. AU - He, L. J. AU - Wang, Y. AU - Li, Y. Y. AU - Lou, Y. AU - Zhang, G. B. PY - 2015 DA - 2015// TI - Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy JO - Cancer Chemother Pharmacol VL - 76 UR - https://doi.org/10.1007/s00280-015-2773-0 DO - 10.1007/s00280-015-2773-0 ID - Wang2015 ER - TY - JOUR AU - Bagley, S. J. AU - Kothari, S. AU - Aggarwal, C. AU - Bauml, J. M. AU - Alley, E. W. AU - Evans, T. L. PY - 2017 DA - 2017// TI - Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer JO - Lung Cancer VL - 106 UR - https://doi.org/10.1016/j.lungcan.2017.01.013 DO - 10.1016/j.lungcan.2017.01.013 ID - Bagley2017 ER - TY - JOUR AU - Scilla, K. A. AU - Bentzen, S. M. AU - Lam, V. K. AU - Mohindra, P. AU - Nichols, E. M. AU - Vyfhuis, M. A. PY - 2017 DA - 2017// TI - Neutrophil-lymphocyte ratio is a prognostic marker in patients with locally advanced (stage IIIA and IIIB) non-small cell lung Cancer treated with combined modality therapy JO - Oncologist. VL - 22 UR - https://doi.org/10.1634/theoncologist.2016-0443 DO - 10.1634/theoncologist.2016-0443 ID - Scilla2017 ER -